EFI 2021 Virtual Session: AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
Optimizing For The Long-Term Success Of Transplant Patients
Tackling Health Equity in Organ Transplantation
2021 HLA Webinar Series #2: The role of HLA Pseudogenes, non-classical genes and non-coding sequences in…
EFI 2021 Virtual Symposium – Revolutionizing Post-Transplant Monitoring: Better Outcomes start with…
2021 HLA Webinar Series #4:Direct genetic comparisons between unrelated HSCT Donor / Patient Pairs with…
Regional Webinar Series: Surveillance of dd-cDNA by Next Generation Sequencing – AlloSeq cDNA Practical…
Managing Your Outcomes in a World of Imperfect Organs and Higher Risk Recipients
Decreasing Transplant Wait Times by Increasing Living Donation
Transplant Quality Outcomes – Part 2: Leveraging New & Existing Tools to Manage Your Quality Outcomes:…
AlloSeq cfDNA Webinar 2021, English + Portuguese–Organ Transplant Surveillance with AlloSeq cfDNA
The Proof is in the Metrics – AlloSeq HCT Case Studies
AlloSeq HCT: The Future of Chimerism Testing – Leading Change by Next Generation Sequencing
2021 HLA Webinar Series #7: Hybrid-Capture HLA Matching with Alloseq Tx17 – Latest Advances and Case-studies
Streamlined Detection of Chimerism Using NGS – Advances of AlloSeq HCT Assay
2021 HLA Webinar Series #6: Revolutionizing Engraftment Monitoring – AlloSeq HCT – The Latest…
ESOT 2023: Adopting dd-cfDNA for Solid Organ Surveillance: Raising the Standards of Transplant Care
Comprehensive HCT Software Quality Metrics – Advanced Training
Merge Ahead: The New OPO Landscape & Ways Your OPO Can Prepare
2020 HLA Webinar Series #2: Meet-The-Expert – AlloSeq Assign Software Demo and Analysis
2020 HLA Webinar Series #3: Meet-The-Expert – AlloSeq Assign: Advanced Options and Difficult Sample
Leverage the Power of Hybrid-capture HLA Typing with New AlloSeq Assign
ESOT 2021 – Symposium – Changing the Transplant Care Paradigm Advanced Strategies for Allograft…
Improving your CareDx Surveillance Testing Workflows